-
- Hong Anh T Tu, Mark H Rozenbaum, Pieter T de Boer, Albert C Noort, and Maarten J Postma.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada. thihonganh.tu@utoronto.ca
- Bmc Infect Dis. 2013 Jan 30; 13: 54.
BackgroundTo update a cost-effectiveness analysis of rotavirus vaccination in the Netherlands previously published in 2011.MethodsThe rotavirus burden of disease and the indirect protection of older children and young adults (herd protection) were updated.ResultsWhen updated data was used, routine infant rotavirus vaccination in the Netherlands would potentially become an even more cost-effective strategy than previously estimated with the incremental cost per QALY at only €3,000-4,000. Break-even total vaccination costs were indicated at €92-122, depending on the applied threshold.ConclusionsWe concluded that the results on potentially favourable cost-effectiveness in the previous study remained valid, however, the new data suggested that previous results might represent an underestimation of the economic attractiveness of rotavirus vaccination.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..